# <scp>SGLT2</scp> inhibition improves endothelium‐independent vasodilatory function in type 2 diabetes: A double‐blind, randomized, placebo‐controlled crossover trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/scp-sglt2-scp-inhibition-improves-endothelium-independent-vasodilatory-function/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Didde Kidmose Kristensen,Frank Holden Mose,Niels Henrik Buus,Camilla Lundgreen Duus,Frederik Husum Mårup,Jesper Nørgaard Bech,Steffen Flindt Nielsen |
| Citations | 9 |
| DOI | 10.1111/dom.16097 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4404864087 |
| PMID | 39610328 |
| Type | article |
| Year | 2024 |

## Paper authors

- [Frederik Husum Mårup](https://scholariq.org/researchers/frederik-husum-marup/)

## Paper journal

- [Diabetes Obesity and Metabolism](https://scholariq.org/journals/diabetes-obesity-and-metabolism/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Nitric Oxide and Endothelin Effects](https://scholariq.org/topics/nitric-oxide-and-endothelin-effects/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.